Evoke Wealth, LLC Edwards Lifesciences Corp Transaction History

Evoke Wealth, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$61.71 - $77.76 $2.62 Million - $3.3 Million	42,395 New	42,395 $3.23 Million
Q3 2022 Nov 07, 2022	SELL	$82.37 - $107.29 $906 - $1,180	-11 Reduced 7.38%	138 $11,000
Q2 2022 Aug 04, 2022	SELL	$86.5 - $128.27 $6,055 - $8,978	-70 Reduced 31.96%	149 $14,000
Q1 2022 May 10, 2022	BUY	$101.96 - $128.34 $713 - $898	7 Added 3.3%	219 $26,000
Q4 2021 Feb 09, 2022	SELL	$106.37 - $130.68 $106 - $130	-1 Reduced 0.47%	212 $27,000
Q3 2021 Nov 12, 2021	SELL	$102.91 - $122.75 $2,469 - $2,946	-24 Reduced 10.13%	213 $24,000
Q2 2021 Aug 05, 2021	SELL	$83.84 - $104.76 $4,275 - $5,342	-51 Reduced 17.71%	237 $25,000
Q1 2021 May 13, 2021	BUY	$78.68 - $90.67 $11,802 - $13,600	150 Added 108.7%	288 $24,000
Q2 2020 Aug 10, 2020	BUY	$57.54 - $76.95 $5,005 - $6,694	87 Added 170.59%	138 $10,000
Q1 2020 May 07, 2020	SELL	$52.41 - $81.0 $1,939 - $2,997	-37 Reduced 42.05%	51 $9.62 Million
Q4 2019 Feb 07, 2020	SELL	$71.7 - $82.09 $286 - $328	-4 Reduced 4.35%	88 $20.5 Million
Q3 2019 Nov 12, 2019	BUY	$61.55 - $75.43 $5,662 - $6,939	92 New	92 $20.2 Million

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Evoke Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Evoke Wealth, LLC with notifications on news.